摘要
二尖瓣反流(Mitral valve regurgitation,MR)逐渐成为心脏瓣膜病中最常见的疾病之一。虽然外科手术在治疗MR中起到重要作用,但由于围手术期的风险过大、老年人基础情况较差等原因,许多患者禁忌外科手术。近年来,经导管治疗MR装置的出现,给治疗MR带来了新的选择,但同时也面临着许多挑战。本文综述了经导管治疗MR装置的技术特征及其临床试验的结果。
Mitral valve regurgitation(MR) is the commonest valvular disease. Although surgery plays an important role in the treatment of MR, many patients are prohibitive for conventional surgery due to the high perioperative risk and older age. In recent years, the development of transcatheter mitral valve therapies has offered new options for the treatment of MR, but it also faces many challenges. This article reviews the technical characteristics of transcatheter MR devices and its results of clinical trials.
作者
宁小平
李宁
安朝
陆方林
NING Xiao-ping;LI Ning;AN Zhao;LU Fang-lin(Department of cardiovascular surgery,Changhai hospital affiliated to the Naval Medical Univesity,Shanghai 200433,China)
出处
《中国心血管病研究》
CAS
2021年第6期551-556,共6页
Chinese Journal of Cardiovascular Research
关键词
二尖瓣反流
功能性二尖瓣反流
退行性二尖瓣反流
经导管二尖瓣修复术
经导管二尖瓣植入术
Mitral valve regurgitation
Functional mitral regurgitation
Degenerative mitral regurgitation
Transcatheter mitral valve repair
Transcatheter mitral valve replacement